Kelyniam Global 公布了 2023 年财务业绩，单位数量略有增长，收入下降 12%，第四季度增长 40%。 Kelyniam Global reported 2023 financial results with slight unit growth, 12% revenue decrease, and 40% Q4 growth.

定制颅骨植入物制造商 Kelyniam Global 公布了 2023 年财务业绩。 Kelyniam Global, a custom cranial implant maker, reported financial results for 2023. 该公司在 2022 年实现了销量小幅增长，​​部分原因是第四季度创纪录的季度销量。 The company achieved slight unit volume growth over 2022, partly due to a record quarterly unit sales in Q4. 然而，由于 2023 年初对人员和基础设施的战略投资，全年总收入下降了 12%。 However, total revenue decreased 12% for the year due to strategic investments in personnel and infrastructure in early 2023. 第四季度的销量和收入比上一季度增长了 40%。 Q4 showed a 40% increase in unit and revenue growth over the previous quarter.